3-{1-[(tert-butoxy)carbonyl]piperidin-3-yl}benzoic acid, 97.0%, 100mg

Microliter syringe GASTIGHT® series 1000, 5.0 ml, 1005 TLL, 1 piece

3-(1-Aminoethyl)oxetan-3-ol, 98%, 1g

1-(3,5-Dimethyl-1h-pyrazol-1-yl)-2-(thiophen-2-yl)ethan-1-one, 95%, 500mg

4-Amino-3-fluorobenzotrifluoride, 98.0%, 25g

(5-Fluoro-2-(N-methylsulfamoyl)phenyl)boronic acid, 95.0%, 1g

1-(3-Bromopropoxy)-4-fluorobenzene, 97%, 5g

Dichloromethane, ROTIPURAN®, min. 99.5%, pa, ACS, ISO, 2.5 l, glass packaging

(R)-3-Oxocyclopentanecarboxylic acid, 95.0%, 1g

2-Ethyl-4,5,6,7-tetrahydro-2h-indazol-3-amine, 95+%, 5g

3-Hydroxy-4-methyl-2-nitrobenzoic acid, 95.0%, 1g

4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine hydrochloride, 95.0%, 5g

CITCO, 98%, 50mg